InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,639.06
(
0.98%
)
US TECH 100
19,879.80
(
1.03%
)
Dow Jones
40,127.50
(
0.94%
)
Brent Oil
84.86
(
-0.30%
)
Bitcoin
58,166.36
(
1.42%
)
Post# of 252585
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120031
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: apljack post# 194293

Wednesday, 08/12/2015 5:33:14 PM

Wednesday, August 12, 2015 5:33:14 PM

Post# of 252585

MCUJF—…if they can double sales to $30 million,…there is at least a technical attractiveness here for a modest investment.

Why would sales of Aggrestat double this late in the game? Aggrestat has been on the market since 1996, and there are several newer and better options for platelet inhibition.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up